New patent for Janssen Biotech drug BALVERSABy DrugPatentWatch – Make Better Decisions / May 11, 2024 Annual Drug Patent Expirations for BALVERSA Balversa is a drug marketed by Janssen Biotech and is included in one NDA. It is available from one supplier. There are six patents…Source